Alimera Sciences Announces Italian Patients Now Being Treated With ILUVIEN® ILUVIEN is fully reimbursable as a hospital-administered therapy in Italy
12 July 2017
ATLANTA, July 12, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization, research, and development of prescription ophthalmic pharmaceuticals, today announced that patients are now being treated in...
> read on